Cheryl Cohen, Director at ImmunityBio, Inc. (IBRX), sold 39,578 shares at $10.00 ($399K) on 2021-08-20, disclosed to the SEC on 2021-08-24.
Open-market sale of $399k IBRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.00 | 9,976 | $100K | 25.0% |
| 2 | $10.12 | 14,801 | $150K | 37.5% |
| 3 | $10.12 | 14,801 | $150K | 37.5% |
| Total | $10.09 avg | 39,578 | $399K | 100% |
| Filing → |
| IBRX | SELL | 2021-08-19 | $900K | — | Filing → |
| NK | SELL | 2020-08-13 | $299K | — | Filing → |
| VTL | SELL | 2018-09-14 | $2K | — | Filing → |